4//SEC Filing
Bunker Kevin D. 4
Accession 0001725160-22-000179
CIK 0001725160other
Filed
Oct 2, 8:00 PM ET
Accepted
Oct 3, 6:40 PM ET
Size
9.5 KB
Accession
0001725160-22-000179
Insider Transaction Report
Form 4
Bunker Kevin D.
Chief Operating Officer
Transactions
- Award
Common Stock
2022-10-03+50,000→ 814,110 total - Award
Stock Option (Right to Buy)
2022-10-03+50,000→ 50,000 totalExercise: $22.21Exp: 2032-10-02→ Common Stock (50,000 underlying)
Holdings
- 95,000(indirect: See Footnote)
Common Stock
- 350(indirect: As UTMA custodian for sons)
Common Stock
Footnotes (3)
- [F1]Represents restricted stock units ("RSUs") granted by the Issuer under the Zentalis Pharmaceuticals, Inc. 2020 Incentive Award Plan, as amended (the "2020 Plan"). The RSUs will vest over two years: 1/3 of the RSUs will vest on the first anniversary of the date of grant, and the remaining 2/3 of the RSUs will vest on the second anniversary of the date of grant.
- [F2]Represents shares nominally held by Sundog Ranch, Inc. on behalf of the Bunker Family Protection Trust, the sole shareholder of Sundog Ranch, Inc. The Reporting Person and his wife are the primary beneficiaries of the Bunker Family Protection Trust and the Reporting Person and his wife are also directors of Sundog Ranch, Inc. The Reporting Person disclaims beneficial ownership of the securities held by Sundog Ranch, Inc. except to the extent of his pecuniary interest therein, if any.
- [F3]The options were granted by the Issuer under the 2020 Plan. The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal monthly installments thereafter, subject to the Reporting Person's continued service with the Issuer.
Documents
Issuer
Zentalis Pharmaceuticals, Inc.
CIK 0001725160
Entity typeother
Related Parties
1- filerCIK 0001807484
Filing Metadata
- Form type
- 4
- Filed
- Oct 2, 8:00 PM ET
- Accepted
- Oct 3, 6:40 PM ET
- Size
- 9.5 KB